Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP

European Respiratory Journal

Volumn 41, Issue 1, 2013, Pages 123-130

  Engel, Madelon F ^a   Postma, Douwe F ^a   Hulscher, Marlies E J L ^c   Van Berkhout, Ferdinand Teding ^a   Emmelot Vonk, Marielle H ^a   Sankatsing, Sanjay ^b   Gaillarde, Carlo A J M ^d,e   Bruns, Anke H W ^a,d   Hoepelman, Andy I M ^a   Oosterheert, Jan Jelrik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEANDER MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic treatment; Community acquired pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

AGED; ARTICLE; BREATHING RATE; CLINICAL EVALUATION; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HIGH TEMPERATURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN THERAPY; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES;

EID: 84872183859     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00029412     Document Type: Article

References (24)

1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27-S72.
2. Athanassa Z, Makris G, Dimopoulos G, et al. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis. Drugs 2008; 68: 2469-2481.
3. Oosterheert JJ, Bonten MJ, Schneider MM, et al. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 2006; 333: 1193.
4. Arnold FW, LaJoie AS, Brock GN, et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 2009; 169: 1515-1524.
5. Schouten JA, Prins JM, Bonten MJ, et al. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med 2005; 63: 323-335.
6. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1-iii55.
7. Schouten JA, Hulscher ME, Natsch S, et al. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study. Qual Saf Health Care 2007; 16: 143-149.
8. Hagaman JT, Yurkowski P, Trott A, et al. Getting physicians to make "the switch": the role of clinical guidelines in the management of community-acquired pneumonia. Am J Med Qual 2005; 20: 15-21.
9. Schouten JA, Hulscher ME, Trap-Liefers J, et al. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial. Clin Infect Dis 2007; 44: 931-941.
10. Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 2010; 10: 167-175.
11. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003; 362: 1225-1230.
12. Baker R, Camosso-Stefinovic J, Gillies C, et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2010; 3: CD005470.
13. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8: 1-72.
14. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382.
15. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
16. Ramirez JA, Srinath L, Ahkee S, et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med 1995; 155: 1273-1276.
17. Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998; 279: 1452-1457.
18. Menendez R, Torres A, Rodriguez de Castro F, et al. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis 2004; 39: 1783-1790.
19. Barlow G, Nathwani D, Williams F, et al. Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis. Thorax 2007; 62: 67-74.
20. Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000; 283: 749-755.
21. Barlow G, Nathwani D, Myers E, et al. Identifying barriers to the rapid administration of appropriate antibiotics in community- acquired pneumonia. J Antimicrob Chemother 2008; 61: 442-451.
22. Halm EA, Switzer GE, Mittman BS, et al. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia?J Gen Intern Med 2001; 16: 599-605.
23. Hospital Admissions Pneumonia, Statistics Netherlands [Ziekenhuisopnamen pneummonie, Centraal Bureau voor Statistiek CBS]. http://statline.cbs.nl/ StatWeb/publication/?VW5T&DM5SLNL&PA571862ned&LA5NL Date last accessed: October 23, 2012.
24. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding kostenonderzoek (eng. Manual cost research) 2010. www.cvz.nl/binaries/live/cvzinternet/hst- content/nl/documenten/losse-publicaties/handleiding-kostenonderzoek-2010.pdf Date last accessed: October 23, 2012.